Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-02-23

FDA Approved: BRIVARACETAM — Original Application (Zhejiang Poly Pharm. Co., Ltd.)

View source ↗

Summary

FDA approved Zhejiang Poly Pharm. Co., Ltd.'s brivaracetam as a generic version, expanding access to the antiepileptic medication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIVARACETAM (brivaracetam)

Snippet

ORIG AP for BRIVARACETAM (BRIVARACETAM)